Adjunct to diet & exercise for the treatment of adults, adolescents & childn ≥10 yr w/ insufficiently controlled type 2 DM, as monotherapy when metformin is considered inappropriate due to intolerance or contraindications, or in addition to other medicinal products for the treatment of DM.
Do not administer by IV or IM. Do not use in patients w/ type 1 DM or for the treatment of diabetic ketoacidosis. Not a substitute for insulin. Associated w/ transient GI adverse reactions. Risk of developing acute pancreatitis. Reports of thyroid adverse events (eg, goitre), particularly in patients w/ pre-existing thyroid disease. Increased risk of hypoglycaemia in combination w/ a sulfonylurea or insulin. Potential risk of dehydration. Not recommended in patients w/ CHF NYHA class IV; inflammatory bowel disease & diabetic gastroparesis; ESRD; severe hepatic impairment. Advise patients to avoid hypoglycaemia while driving & using machines. Do not use during pregnancy & breast-feeding. No data available for childn <10 yr.
Sign Out
 6 mg_mLab179de1-f9f8-4b55-9f3a-a32001078111.GIF)
